KUALA LUMPUR (Reuters) – The Malaysian Ministry of Health announced Friday (July 16) that it had granted conditional approval for the emergency use of the COVID-19 vaccine manufactured by Chinese company Sinopharm.
The Sinopharm vaccine in Malaysia has been registered by pharmaceutical company Duopharma, chief health officer Noor Hisham Abdullah said in a statement.
Duopharma previously announced an agreement to supply the Malaysian government with 6.4 million doses of the Russian-made Sputnik V vaccine.
The company did not immediately respond to a request for comment on the Health Ministry’s announcement on Sinopharm.
Authorities have also granted conditional approval to the Janssen COVID-19 vaccine made by US drug maker Johnson & Johnson and made in Belgium, Dr Noor Hisham said.
Malaysia had previously approved another batch of Janssen vaccine that had been given the green light for emergency use by the World Health Organization.
READ: Malaysia to stop using Sinovac COVID-19 vaccine after supplies end: Minister of Health
The approvals come a day after Malaysia’s health ministry said it would stop administering the COVID-19 vaccine produced by Chinese company Sinovac once its supplies run out because it has a sufficient number of others. vaccines for his program.
Malaysia launched its national COVID-19 vaccination program on February 24. She administered a total of 12,647,558 doses of COVID-19 vaccine on Thursday, with more than 4 million people – or 12.3% of the population – fully vaccinated so far.
READ: Malaysian government plans to give ‘leeway’ to people fully vaccinated against COVID-19: PM Muhyiddin
READ: Desperate Malaysians wave white flags as a cry for help to survive COVID-19 lockdown
Prime Minister Muhyiddin Yassin said on Thursday that the government is considering the possibility of giving ‘leeway’ to people who have completed the full COVID-19 vaccination regimen, including allowing them to dine in restaurants and travel between states.
Malaysia reported 13,215 new cases of COVID-19 on Thursday, setting a record for the third day in a row. To date, authorities have reported around 880,000 cases and more than 6,600 deaths.
MARK THIS: Our Comprehensive Coverage of the COVID-19 Pandemic and Its Developments
Download our app or subscribe to our Telegram channel for the latest updates on the coronavirus outbreak: https://cna.asia/telegram